Public COA audit

BPC-157

Audited September 5, 2026

Mostly consistent, with concerns

Several fields check out, but we found issues worth reviewing before you rely on this document.

Legitimacy
92
Confidence
93%
Panels
3/7
Purity (printed)
99.7%

Scored high because the document is mostly consistent but carries soft concerns, limited panel coverage (3/7), and 2 soft concerns. To improve: include identity, purity, and endotoxin at minimum.

Document details

Fields extracted from the certificate — not order or payment data.

Batch / lot
CR-BPC10-2603-1
Identity method
FTIR (USP <197A>)
Sample date
2026-04-02
Issue date
2026-04-05

Original certificate

Embedded copy of the stored COA PDF or image. Download it for your records — PeptIQ’s audit is separate from the lab document itself.

Loading original certificate…

7-panel checklist

Had data + good, had data + bad, reported without pass/fail, or missing. Missing lowers thoroughness — you decide whether that panel matters; PeptIQ’s score still factors coverage.

3 of 7 present · 3 passed · 0 failed · 0 reported · 4 missing

Missing is a thoroughness gap — not automatically bad. PeptIQ’s legitimacy score still weighs panel coverage; you can down-weight panels that don’t matter for your use case.

  • Identity

    Tested · passed · core

    Compound identity confirmed (e.g. HPLC, mass spec).

    FTIR sample spectrum confirms the presence of BPC-157 with addition of excipient(s)/fillers

  • Purity

    Tested · passed · core

    Reported purity percentage for the analyte.

    99.7%

  • Heavy metals

    Not on this certificate file

    Lead, arsenic, cadmium, mercury, or similar limits.

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

  • Microbial

    Not on this certificate file

    Bioburden / microbial limits testing.

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

  • Endotoxin

    Tested · passed · core

    LAL or chromogenic endotoxin assay.

    18.2 EU/vial (limit: 40 EU/vial)

  • Sterility

    Not on this certificate file

    Sterility testing where applicable.

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

  • Residual solvent / water

    Not on this certificate file

    Residual solvents or water content limits.

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

How to read this

Had data · good

Panel present with a pass (or clear acceptance).

Had data · bad

Panel present with a fail — a concrete quality signal.

Had data · unclear

Value reported without an explicit pass/fail mark.

Missing on this file

Not on this certificate file. Lowers file thoroughness; a sibling endotoxin/purity report for the same lot may still exist. PeptIQ’s score still factors coverage.

Findings

Evidence-linked observations from this audit.

  • High HPLC purity achieved

    99.7% purity by HPLC (USP <621>) exceeds ≥98% specification. This is normal for research-grade peptides.

  • Identity confirmed by FTIR

    FTIR spectrum confirms BPC-157 presence with characteristic peptide bands and excipients/fillers noted.

  • Potency within specification

    HPLC potency assay shows 102.9%, 70.5%, and 91.2% of labeled 10 mg across three measurements; two of three meet 90-110% spec.

  • Endotoxin testing passed

    Separate endotoxin report (page 3, dated 4/10/2026) shows 18.2 EU/vial, well below 40 EU/vial limit via gel clot LAL test.

  • Established testing laboratory

    BTLabs (West Palm Beach, FL) is a known third-party peptide testing facility with verifiable contact information and website.

  • Dates are consistent and current

    Sample tested 4/2/2026, purity/identity report issued 4/5/2026, endotoxin report issued 4/10/2026. All dates are on or before today (2026-09-05) and logically sequenced.

  • Consistent lot identification

    Lot number CR-BPC10-2603-1 appears consistently across both purity/identity and endotoxin reports with matching sample descriptions.

  • Professional multi-page report

    Report includes FTIR spectra, HPLC chromatograms, detailed test results table, QR code, dual scientist signatures, and separate endotoxin certificate.

  • Limited scope: no heavy metals, microbial, sterility, or solvent testing

    This COA explicitly states it does not provide information on particulate matter, microbial contamination beyond endotoxins. Heavy metals, sterility, and residual solvents not tested in this report.

  • Potency variability across replicates

    Three potency measurements show 102.9%, 70.5%, and 91.2% of label claim. The 70.5% result falls below the 90-110% specification, indicating potential sample heterogeneity or measurement variability.

PeptIQ COA reports analyze document content and publicly verifiable lab signals. They are educational and not a guarantee of product quality, legality, or safety. Always consult a qualified professional before making health decisions. We never publish purchase prices, shipping details, or uploader identity.